These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21922468)

  • 1. An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.
    Widrick JJ; Jiang S; Choi SJ; Knuth ST; Morcos PA
    Muscle Nerve; 2011 Oct; 44(4):563-70. PubMed ID: 21922468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy.
    Moulton HM; Wu B; Jearawiriyapaisarn N; Sazani P; Lu QL; Kole R
    Ann N Y Acad Sci; 2009 Sep; 1175():55-60. PubMed ID: 19796077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage.
    Gehrig SM; Ryall JG; Schertzer JD; Lynch GS
    Exp Physiol; 2008 Nov; 93(11):1190-8. PubMed ID: 18567600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino.
    Wu B; Lu P; Benrashid E; Malik S; Ashar J; Doran TJ; Lu QL
    Gene Ther; 2010 Jan; 17(1):132-40. PubMed ID: 19759562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice.
    Wu B; Li Y; Morcos PA; Doran TJ; Lu P; Lu QL
    Mol Ther; 2009 May; 17(5):864-71. PubMed ID: 19277018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
    Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
    Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
    Takeshima Y; Yagi M; Wada H; Matsuo M
    Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscle.
    Vitiello L; Bassi N; Campagnolo P; Zaccariotto E; Occhi G; Malerba A; Pigozzo S; Reggiani C; Ausoni S; Zaglia T; Gamba P; Baroni MD; Ditadi AP
    Neuromuscul Disord; 2008 Aug; 18(8):597-605. PubMed ID: 18602263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
    Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14814-9. PubMed ID: 18806224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice.
    Gregorevic P; Plant DR; Lynch GS
    Muscle Nerve; 2004 Sep; 30(3):295-304. PubMed ID: 15318340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
    Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of L-arginine benefits mdx skeletal muscle function.
    Barton ER; Morris L; Kawana M; Bish LT; Toursel T
    Muscle Nerve; 2005 Dec; 32(6):751-60. PubMed ID: 16116642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weekly oral prednisolone improves survival and strength in male mdx mice.
    Keeling RM; Golumbek PT; Streif EM; Connolly AM
    Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles.
    Lu QL; Rabinowitz A; Chen YC; Yokota T; Yin H; Alter J; Jadoon A; Bou-Gharios G; Partridge T
    Proc Natl Acad Sci U S A; 2005 Jan; 102(1):198-203. PubMed ID: 15608067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS; Boulanger-Piette A; Bossé S; Argaw A; Hamoudi D; Marcadet L; Gamu D; Fajardo VA; Yagita H; Penninger JM; Russell Tupling A; Frenette J
    Acta Neuropathol Commun; 2018 Apr; 6(1):31. PubMed ID: 29699580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle function and running activity in mouse models of hereditary muscle dystrophy: impact of double knockout for dystrophin and the transcription factor MyoD.
    Mangner N; Adams V; Sandri M; Hoellriegel R; Hambrecht R; Schuler G; Gielen S
    Muscle Nerve; 2012 Apr; 45(4):544-51. PubMed ID: 22431088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.